BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30182347)

  • 21. Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
    Kantarjian HM; Kurzrock R; Talpaz M
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):389-404. PubMed ID: 2182598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias.
    Schuler E; Schroeder M; Neukirchen J; Strupp C; Xicoy B; Kündgen A; Hildebrandt B; Haas R; Gattermann N; Germing U
    Leuk Res; 2014 Dec; 38(12):1413-9. PubMed ID: 25444076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
    Xu Y; McKenna RW; Karandikar NJ; Pildain AJ; Kroft SH
    Am J Clin Pathol; 2005 Nov; 124(5):799-806. PubMed ID: 16203279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined.
    Elliott MA
    Best Pract Res Clin Haematol; 2006; 19(3):571-93. PubMed ID: 16781489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis.
    Arbab Jafari P; Ayatollahi H; Sadeghi R; Sheikhi M; Asghari A
    Hematology; 2018 Dec; 23(10):778-784. PubMed ID: 29757120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
    Melo JV; Myint H; Galton DA; Goldman JM
    Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune thrombocytopenia in chronic myelomonocytic leukemia.
    Hadjadj J; Michel M; Chauveheid MP; Godeau B; Papo T; Sacre K
    Eur J Haematol; 2014 Dec; 93(6):521-6. PubMed ID: 24913055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical management of chronic myelomonocytic leukemia.
    Padron E; Komrokji R; List AF
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):172-8. PubMed ID: 24927265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
    Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
    Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.
    Ramadan H; Duong VH; Al Ali N; Padron E; Zhang L; Lancet JE; List AF; Komrokji RS
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S64-6. PubMed ID: 27521328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.
    Kongtim P; Popat U; Jimenez A; Gaballa S; El Fakih R; Rondon G; Chen J; Bueso-Ramos C; Borthakur G; Pemmaraju N; Garcia-Manero G; Kantarjian H; Alousi A; Hosing C; Anderlini P; Khouri IF; Kebriaei P; Andersson BS; Oran B; Rezvani K; Marin D; Shpall EJ; Champlin RE; Ciurea SO
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):47-53. PubMed ID: 26343946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: a report of 12 patients].
    Sun YQ; Xu LP; Liu DH; Zhang XH; Han W; Chen H; Wang FR; Wang JZ; Wang Y; Chen YH; Liu KY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):113-6. PubMed ID: 23611216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
    van der Helm LH; Alhan C; Wijermans PW; van Marwijk Kooy M; Schaafsma R; Biemond BJ; Beeker A; Hoogendoorn M; van Rees BP; de Weerdt O; Wegman J; Libourel WJ; Luykx-de Bakker SA; Minnema MC; Brouwer RE; Croon-de Boer F; Eefting M; Jie KS; van de Loosdrecht AA; Koedam J; Veeger NJ; Vellenga E; Huls G
    Br J Haematol; 2011 Dec; 155(5):599-606. PubMed ID: 21981697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia.
    Tang G; Fu B; Hu S; Lu X; Tang Z; Li S; Jabbar K; Khoury JD; Medeiros LJ; Wang SA
    Am J Hematol; 2015 Oct; 90(10):882-7. PubMed ID: 26148174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.
    Padron E; Steensma DP
    Curr Opin Hematol; 2015 Mar; 22(2):163-70. PubMed ID: 25575034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case-control study of chronic myelomonocytic leukemia (CMML) in Shanghai, China: evaluation of risk factors for CMML, with special focus on benzene.
    Gross SA; Irons RD; Scott PK; Galbraith D; Wang XQ; Chen Y; Paustenbach D
    Arch Environ Occup Health; 2012; 67(4):206-18. PubMed ID: 23074978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generalized palisaded neutrophilic and granulomatous dermatitis-a cutaneous manifestation of chronic myelomonocytic leukemia? A clinical, histopathological, and molecular study of 3 cases.
    Federmann B; Bonzheim I; Yazdi AS; Schmidt J; Fend F; Metzler G
    Hum Pathol; 2017 Jun; 64():198-206. PubMed ID: 28442268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic lymphocytic leukemia coexisting with chronic myelomonocytic leukemia.
    Ferrara F; Del Vecchio L; Antonolfi I; Mele G; Rametta V; Cimino R
    Haematologica; 1992; 77(2):171-3. PubMed ID: 1398303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.